Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 17

1.

Advantages of isovolemic hemodilution-red cell exchange therapy to prevent recurrent stroke in sickle cell anemia patients.

Sarode R, Matevosyan K, Rogers ZR, Burner JD, Rutherford C.

J Clin Apher. 2011;26(4):200-7. doi: 10.1002/jca.20294. Epub 2011 Jul 22.

PMID:
21786315
2.

[Assessment of the use of transfusion therapy and complications in orthopedic surgery in patients with sickle-cell anemia: retrospective study].

Ould amar AK, Delattre O, Godbille C, Béra O, Halbout PA, Catonné Y.

Transfus Clin Biol. 2003 Apr;10(2):61-6. Review. French.

PMID:
12763144
3.

Clinical significance of RBC alloantibodies and autoantibodies in sickle cell patients who received transfusions.

Aygun B, Padmanabhan S, Paley C, Chandrasekaran V.

Transfusion. 2002 Jan;42(1):37-43. Review.

PMID:
11896310
4.
5.

Indications for red cell transfusion in sickle cell disease.

Ohene-Frempong K.

Semin Hematol. 2001 Jan;38(1 Suppl 1):5-13. Review.

PMID:
11206961
6.

The prevention and management of stroke in sickle cell anaemia.

Qureshi N, Lubin B, Walters MC.

Expert Opin Biol Ther. 2006 Nov;6(11):1087-98. Review.

PMID:
17049007
7.

Current issues with blood transfusions in sickle cell disease.

Vichinsky EP.

Semin Hematol. 2001 Jan;38(1 Suppl 1):14-22. Review.

PMID:
11206956
8.

[Transfusion in sickle cell anemia].

Germain S, Brahimi L, Rohrlich P, Benkerrou M, Gerota I, Ballerini P.

Pathol Biol (Paris). 1999 Jan;47(1):65-72. Review. French.

PMID:
10081782
9.

Prevention and management of strokes in patients with sickle cell disease.

Abboud MR, Atweh GF.

Curr Hematol Rep. 2006 Mar;5(1):15-22. Review.

PMID:
16537042
10.

Sickle cell anaemia: progress in pathogenesis and treatment.

Ballas SK.

Drugs. 2002;62(8):1143-72. Review.

PMID:
12010077
11.

Management of Patients with Sickle Cell Disease Using Transfusion Therapy: Guidelines and Complications.

Chou ST, Fasano RM.

Hematol Oncol Clin North Am. 2016 Jun;30(3):591-608. doi: 10.1016/j.hoc.2016.01.011. Review.

PMID:
27112998
12.

Erythrocytapheresis for chronic transfusion therapy in sickle cell disease: survey of current practices and review of the literature.

Kelly S, Quirolo K, Marsh A, Neumayr L, Garcia A, Custer B.

Transfusion. 2016 Nov;56(11):2877-2888. doi: 10.1111/trf.13800. Epub 2016 Oct 19. Review.

PMID:
27759170
13.

Sickle cell disease: a review.

Roseff SD.

Immunohematology. 2009;25(2):67-74. Review.

PMID:
19927623
14.

Out with the bad and in with the good; red cell exchange, white cell reduction, and platelet reduction.

Marques MB, Singh N, Reddy VV.

J Clin Apher. 2014 Aug;29(4):220-7. doi: 10.1002/jca.21332. Epub 2014 May 14. Review.

PMID:
24828305
15.

Sickle Cell Disease and Stroke: Diagnosis and Management.

Lawrence C, Webb J.

Curr Neurol Neurosci Rep. 2016 Mar;16(3):27. doi: 10.1007/s11910-016-0622-0. Review.

PMID:
26873822
16.

Sickle cell disease and stroke.

Talahma M, Strbian D, Sundararajan S.

Stroke. 2014 Jun;45(6):e98-100. doi: 10.1161/STROKEAHA.114.005144. Epub 2014 May 1. Review. No abstract available.

17.

Hypertransfusion therapy in sickle cell disease in Nigeria.

Adewoyin AS, Obieche JC.

Adv Hematol. 2014;2014:923593. doi: 10.1155/2014/923593. Epub 2014 Aug 7. Review.

Supplemental Content

Support Center